David Margolin
- Pathology and Forensic Medicine top 0.2%
- Multiple Sclerosis Research Studies 69
- Neurology top 1%
- Peripheral Neuropathies and Disorders 13
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies 20
- Systemic Lupus Erythematosus Research 10
- Immunology top 2%
- Immunotherapy and Immune Responses 14
- Oncology top 2%
- Polyomavirus and related diseases 15
-
- Monoclonal and Polyclonal Antibodies Research 13
-
- Acute Lymphoblastic Leukemia research 12
- Co-authors
- Alasdair ColesKrzysztof SelmajEdward FoxD. A. S. CompstonEva HavrdováDouglas L. ArnoldStephen LakeJeffrey Cohen
- Journals
- Neurology (68 papers)Multiple Sclerosis Journal (11 papers)Journal of the Neurological Sciences (4 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
David Margolin
121 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Pathology and Forensic Medicine 2.8k
- Neurology 1.1k
- Rheumatology 831
- Immunology 1.1k
- Oncology 1.2k
Countries citing papers authored by David Margolin
This map shows the geographic impact of David Margolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Margolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Margolin more than expected).
Fields of papers citing papers by David Margolin
This network shows the impact of papers produced by David Margolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Margolin. The network helps show where David Margolin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Margolin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 16 | |
| 2 | Alemtuzumab demonstrated durable efficacy and safety in CARE-MS I patients switching from SC IFNB-1a: 5-year follow-up after alemtuzumab (TOPAZ study) | 2017 | 1 |
| 3 | 2017 | 0 | |
| 4 | 2017 | 2 | |
| 5 | 2017 | 1 | |
| 6 | Durable Effect of Alemtuzumab on Clinical Outcomes Over 5 years in Treatment-Naive Patients With Active Relapsing-Remitting Multiple Sclerosis Despite Most Patients Not Receiving Treatment for 4 Years: CARE-MS I Extension Study | 2016 | 2 |
| 7 | Alemtuzumab provides durable improvements in clinical outcomes in treatment-naive patients with active relapsing-remitting multiple sclerosis over 6 years in the absence of continuous treatment (CARE-MS I). | 2016 | 7 |
| 8 | Durable suppression of disease activity by alemtuzumab in the absence of continuous treatment over 6 years in patients with active relapsing-remitting multiple sclerosis and an inadequate response to prior therapy (CARE-MS II) | 2016 | 1 |
| 9 | 2016 | 2 | |
| 10 | 2016 | 5 | |
| 11 | 2016 | 7 | |
| 12 | 2015 | 1 | |
| 13 | Pregnancy outcomes in patients with active RRMS who received alemtuzumab in the clinical development program | 2015 | 9 |
| 14 | 2014 | 2 | |
| 15 | 2014 | 0 | |
| 16 | 2013 | 2 | |
| 17 | 2013 | 4 | |
| 18 | 2013 | 1 | |
| 19 | 2013 | 111 | |
| 20 | 2013 | 1 |
About David Margolin
David Margolin is a scholar working on Pathology and Forensic Medicine, Rheumatology, Virology, Neurology and Immunology, having authored 125 papers that have together received 4.0k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (69 papers), Rheumatoid Arthritis Research and Therapies (20 papers), Polyomavirus and related diseases (15 papers), Immunotherapy and Immune Responses (14 papers), Peripheral Neuropathies and Disorders (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Acute Lymphoblastic Leukemia research (12 papers) and Systemic Lupus Erythematosus Research (10 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.8k citations), Neurology (1.1k citations), Rheumatology (831 citations), Immunology (1.1k citations) and Oncology (1.2k citations). David Margolin has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Alasdair Coles, Krzysztof Selmaj, Edward Fox, D. A. S. Compston, Eva Havrdová, Douglas L. Arnold, Stephen Lake, Jeffrey Cohen, Michael Panzara and Howard L. Weiner. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, Journal of the Neurological Sciences, Multiple Sclerosis and Related Disorders and Journal of Neurology Neurosurgery & Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.